Psoriatic Arthritis
Psoriatic arthritis (PsA) is a chronic autoimmune condition that causes inflammation in the joints and is often associated with the skin condition psoriasis, leading to symptoms like joint pain, stiffness, and swelling.
Psoriatic Arthritis: Sonelokimab Treatment Study
We are investigating whether sonelokimab can effectively reduce symptoms in adults with active psoriatic arthritis who have not yet tried biologic treatments. The study will also assess the safety of this new medication compared to a placebo.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have a confirmed diagnosis of psoriatic arthritis (PsA)?
- Are you currently pregnant or breastfeeding?
- Have you had major surgery in the past 6 months?
- Do you have severe heart problems, like a history of heart attack or uncontrolled high blood pressure?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Sonelokimab
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Medical Center Zara-Med EOOD
Dolni Chiflik, Bulgaria
Medical Center Artmed Ltd.
Haskovo, Bulgaria
Medical Center Exacta Medica OOD
Pleven, Bulgaria
Sponsor: MoonLake Immunotherapeutics AG
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.